These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3880490)

  • 1. The in vivo evaluation of poly(lactic acid) microcapsules of pilocarpine hydrochloride.
    Vidmar V; Pepeljnjak S; Jalsenjak I
    J Microencapsul; 1985; 2(4):289-92. PubMed ID: 3880490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(lactic acid) microencapsulated oxytetracycline: in vitro and in vivo evaluation.
    Vidmar V; Smolcić-Bubalo A; Jalsenjak I
    J Microencapsul; 1984; 1(2):131-6. PubMed ID: 6336522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Action of miosis of 1% pilocarpine liposome in rabbits].
    Zhang HC; Yao K
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):343-5. PubMed ID: 12905753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bioactivity and effect of a mixture of pilocarpine and lysine on the pupil and intraocular pressure in rabbits].
    Veselovský J; Oláh Z; Veselovská Z; Veselá A
    Cesk Slov Oftalmol; 1998 Nov; 54(6):353-61. PubMed ID: 9919787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inlfuence of high-viscosity vehicles on miotic effect of pilocarpine.
    Schoenwald RD; Ward RL; DeSantis LM; Roehrs RE
    J Pharm Sci; 1978 Sep; 67(9):1280-3. PubMed ID: 690834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microencapsulation using poly(L-lactic acid). I: Microcapsule properties affected by the preparative technique.
    Jalil R; Nixon JR
    J Microencapsul; 1989; 6(4):473-84. PubMed ID: 2585239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microencapsulation using poly(DL-lactic acid). IV: Effect of storage on the microcapsule characteristics.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(3):375-83. PubMed ID: 2384839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microencapsulation using poly (L-lactic acid) III: Effect of polymer molecular weight on the microcapsule properties.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(1):41-52. PubMed ID: 2308053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microencapsulation using poly(L-lactic acid) IV: Release properties of microcapsules containing phenobarbitone.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(1):53-66. PubMed ID: 2308054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of pluronic F127-based sustained-release ocular delivery systems for pilocarpine using the albino rabbit eye model.
    Desai SD; Blanchard J
    J Pharm Sci; 1998 Oct; 87(10):1190-5. PubMed ID: 9758675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained release ophthalmic formulations of pilocarpine.
    Deshpande SG; Shirolkar S
    J Pharm Pharmacol; 1989 Mar; 41(3):197-200. PubMed ID: 2568450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microencapsulation using poly(DL-lactic acid). I: Effect of preparative variables on the microcapsule characteristics and release kinetics.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(2):229-44. PubMed ID: 2329448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of topical administration of 2.0% pilocarpine on intraocular pressure and pupil size in cats.
    Wilkie DA; Latimer CA
    Am J Vet Res; 1991 Mar; 52(3):441-4. PubMed ID: 2035919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(3):297-325. PubMed ID: 2200861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of influence of rabbit nictitating membrane of miosis effect of pilocarpine.
    DeSantis LM; Schoenwald RD
    J Pharm Sci; 1978 Aug; 67(8):1189-90. PubMed ID: 671268
    [No Abstract]   [Full Text] [Related]  

  • 16. Microencapsulation using poly (L-lactic acid) II: Preparative variables affecting microcapsule properties.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(1):25-39. PubMed ID: 2308052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Examination of hypotensive and miotic effects of different pilocarpine solutions (experimental investigations)].
    Kondrat'eva TS; Denisova TV; Bunin AAi ; Iakovlev AA
    Vestn Oftalmol; 1976; (2):29-31. PubMed ID: 1014180
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative effects of pilocarpine in different vehicles on pupil diameter in albino rabbits and squirrel monkeys.
    Cheeks L; Green K; Stone RP; Riedhammer T
    Curr Eye Res; 1989 Dec; 8(12):1251-8. PubMed ID: 2627795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential distribution across a plasma protein-coated poly(L-lactide) microcapsule surface.
    Makino K; Ohshima H; Kondo T
    J Microencapsul; 1990; 7(2):199-208. PubMed ID: 2329446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pluronic F127-based ocular delivery system containing biodegradable polyisobutylcyanoacrylate nanocapsules of pilocarpine.
    Desai SD; Blanchard J
    Drug Deliv; 2000; 7(4):201-7. PubMed ID: 11195426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.